{"disease":{"id":"thrombotic-microangiopathies","name":"thrombotic microangiopathies"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06727669","title":"Longitudinal Cohort of Thrombosis and Hemostasis Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT05634928","title":"Construction of a Database for TMA","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"The First Affiliated Hospital of Soochow University","has_results":false},{"nct_id":"NCT03252925","title":"A Safety and Efficacy Study of NAC in Patients With TA-TMA","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":170,"lead_sponsor_name":"The First Affiliated Hospital of Soochow University","has_results":true},{"nct_id":"NCT03605511","title":"TTP and aHUS in Complicated Pregnancies","phase":"","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"University College, London","has_results":false},{"nct_id":"NCT06291025","title":"Efficacy and Safety of Immunosuppression, Caplacizumab and Plasma Infusion Without Therapeutic Plasma Exchange in Immune-mediated Thrombotic Thrombocytopenic Purpura","phase":"NA","overall_status":"RECRUITING","enrollment_count":131,"lead_sponsor_name":"University Hospital, Rouen","has_results":false},{"nct_id":"NCT02134171","title":"Early Predictive Factors of Cardiac and Cerebral Involvement in TMA","phase":"NA","overall_status":"COMPLETED","enrollment_count":119,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT07459114","title":"TGD001 Treatment in Thrombotic Microangiopathies","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":70,"lead_sponsor_name":"TargED Biopharmaceuticals B.V.","has_results":false},{"nct_id":"NCT02222545","title":"Safety and Efficacy Study of OMS721 in Patients With Thrombotic Microangiopathies","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":58,"lead_sponsor_name":"Omeros Corporation","has_results":true},{"nct_id":"NCT04949698","title":"Risk Factors and the Effect of Plasma Exchange on Prognosis of Pregnancy-related Thrombotic Microangiopathies","phase":"","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Peking University Third Hospital","has_results":false},{"nct_id":"NCT04745195","title":"Complement Prospective Evaluation of Thrombotic Microangiopathy on Endothelium","phase":"","overall_status":"RECRUITING","enrollment_count":42,"lead_sponsor_name":"Maastricht University Medical Center","has_results":false},{"nct_id":"NCT05996679","title":"Automated Surveillance, Alert, and Rapid Diagnosis of Thrombotic Microangiopathies: the ASARD-TMA Study","phase":"","overall_status":"UNKNOWN","enrollment_count":29,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT03384693","title":"Defibrotide TMA Prophylaxis Pilot Trial","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"University of California, San Francisco","has_results":true},{"nct_id":"NCT03518203","title":"Eculizumab to Treat Thrombotic Microangiopathy/Atypical Hemolytic Uremic Syndrome -Associated Multiple Organ Dysfunction Syndrome in Hematopoietic Stem Cell Transplant Recipients","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":23,"lead_sponsor_name":"Children's Hospital Medical Center, Cincinnati","has_results":true},{"nct_id":"NCT04784455","title":"Nomacopan (rVA576) in Transplant Associated Thrombotic Microangiopathy","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":10,"lead_sponsor_name":"AKARI Therapeutics","has_results":true},{"nct_id":"NCT03205995","title":"Safety and Efficacy Study of OMS721 in Patients With Atypical Hemolytic Uremic Syndrome","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":6,"lead_sponsor_name":"Omeros Corporation","has_results":true},{"nct_id":"NCT04970004","title":"Study in Adult and Pediatric Patients With HSCT-TMA","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Alexion Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT06182410","title":"Defibrotide Prophylaxis of Transplant Associated-Thrombotic Microangiopathy for Neuroblastoma","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"University of California, San Francisco","has_results":false}],"total":17},"guidelines":[],"source":"Drug Landscape verified database"}